DE60325587D1 - Thymidinkinasen aus pflanzen und ihre verwendung - Google Patents
Thymidinkinasen aus pflanzen und ihre verwendungInfo
- Publication number
- DE60325587D1 DE60325587D1 DE60325587T DE60325587T DE60325587D1 DE 60325587 D1 DE60325587 D1 DE 60325587D1 DE 60325587 T DE60325587 T DE 60325587T DE 60325587 T DE60325587 T DE 60325587T DE 60325587 D1 DE60325587 D1 DE 60325587D1
- Authority
- DE
- Germany
- Prior art keywords
- methods
- polynucleotide
- tomato
- plant
- nucleoside analog
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000006601 Thymidine Kinase Human genes 0.000 abstract 5
- 108020004440 Thymidine kinase Proteins 0.000 abstract 5
- 241000196324 Embryophyta Species 0.000 abstract 4
- 238000000034 method Methods 0.000 abstract 4
- 102000040430 polynucleotide Human genes 0.000 abstract 3
- 108091033319 polynucleotide Proteins 0.000 abstract 3
- 239000002157 polynucleotide Substances 0.000 abstract 3
- 241000227653 Lycopersicon Species 0.000 abstract 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 abstract 2
- 239000002777 nucleoside Substances 0.000 abstract 2
- 150000003833 nucleoside derivatives Chemical class 0.000 abstract 2
- HBOMLICNUCNMMY-XLPZGREQSA-N zidovudine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 HBOMLICNUCNMMY-XLPZGREQSA-N 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 230000002159 abnormal effect Effects 0.000 abstract 1
- 230000000443 biocontrol Effects 0.000 abstract 1
- 230000010261 cell growth Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000001415 gene therapy Methods 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 150000004712 monophosphates Chemical class 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 230000001235 sensitizing effect Effects 0.000 abstract 1
- 230000002194 synthesizing effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
- C12N9/1211—Thymidine kinase (2.7.1.21)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/01—Phosphotransferases with an alcohol group as acceptor (2.7.1)
- C12Y207/01076—Deoxyadenosine kinase (2.7.1.76)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
- Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Transplantation (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200200794 | 2002-05-23 | ||
| DKPA200300178 | 2003-02-07 | ||
| PCT/DK2003/000337 WO2003100045A1 (en) | 2002-05-23 | 2003-05-21 | Plant thymidine kinases and their use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60325587D1 true DE60325587D1 (de) | 2009-02-12 |
Family
ID=29585606
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60325587T Expired - Lifetime DE60325587D1 (de) | 2002-05-23 | 2003-05-21 | Thymidinkinasen aus pflanzen und ihre verwendung |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7928206B2 (enExample) |
| EP (1) | EP1509600B1 (enExample) |
| JP (1) | JP2006504403A (enExample) |
| CN (1) | CN1662647A (enExample) |
| AT (1) | ATE419337T1 (enExample) |
| AU (1) | AU2003229543B2 (enExample) |
| CA (1) | CA2485182A1 (enExample) |
| DE (1) | DE60325587D1 (enExample) |
| DK (1) | DK1509600T3 (enExample) |
| ES (1) | ES2320434T3 (enExample) |
| MX (1) | MXPA04011572A (enExample) |
| NZ (1) | NZ536623A (enExample) |
| PT (1) | PT1509600E (enExample) |
| RU (1) | RU2339695C2 (enExample) |
| SI (1) | SI1509600T1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2456937B (en) | 2006-10-24 | 2011-07-13 | Bradley Fixtures Corp | Capacitive sensing for washroom fixture |
| JP5211303B2 (ja) * | 2007-10-25 | 2013-06-12 | 独立行政法人産業技術総合研究所 | 蛋白質の製造方法 |
| CN114107339B (zh) * | 2021-12-09 | 2024-06-07 | 菏泽学院 | 泡桐丛枝植原体胸苷激酶基因引物、基因、融合蛋白、多克隆抗体及其应用 |
| CN117016549B (zh) * | 2023-03-13 | 2024-02-27 | 山东蓬勃生物科技有限公司 | 核苷类化合物及其组合物在促进植物生长中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0758387B1 (en) * | 1994-05-02 | 2001-12-19 | University of Washington | Thymidine kinase mutants |
| US6197743B1 (en) * | 1996-07-26 | 2001-03-06 | The Trustees Of Boston University | Compositions and methods for the treatment of viral disorders |
| CA2306443A1 (en) | 1997-10-14 | 1999-04-22 | Darwin Molecular Corporation | Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities |
| AU4582899A (en) | 1998-06-22 | 2000-01-10 | Board Of Trustees Of The University Of Arkansas, The | Mutated herpes simplex virus type 1 thymidine kinases and uses thereof |
| GB0008966D0 (en) * | 2000-04-13 | 2000-05-31 | Imp College Innovations Ltd | Vectors for gene therapy |
-
2003
- 2003-05-21 NZ NZ536623A patent/NZ536623A/en not_active IP Right Cessation
- 2003-05-21 RU RU2004133390/13A patent/RU2339695C2/ru not_active IP Right Cessation
- 2003-05-21 PT PT03722322T patent/PT1509600E/pt unknown
- 2003-05-21 CA CA002485182A patent/CA2485182A1/en not_active Abandoned
- 2003-05-21 AU AU2003229543A patent/AU2003229543B2/en not_active Ceased
- 2003-05-21 DE DE60325587T patent/DE60325587D1/de not_active Expired - Lifetime
- 2003-05-21 AT AT03722322T patent/ATE419337T1/de not_active IP Right Cessation
- 2003-05-21 SI SI200331542T patent/SI1509600T1/sl unknown
- 2003-05-21 MX MXPA04011572A patent/MXPA04011572A/es active IP Right Grant
- 2003-05-21 ES ES03722322T patent/ES2320434T3/es not_active Expired - Lifetime
- 2003-05-21 CN CN038138425A patent/CN1662647A/zh active Pending
- 2003-05-21 EP EP03722322A patent/EP1509600B1/en not_active Expired - Lifetime
- 2003-05-21 US US10/515,417 patent/US7928206B2/en not_active Expired - Fee Related
- 2003-05-21 DK DK03722322T patent/DK1509600T3/da active
- 2003-05-21 JP JP2004508286A patent/JP2006504403A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2006504403A (ja) | 2006-02-09 |
| RU2339695C2 (ru) | 2008-11-27 |
| RU2004133390A (ru) | 2005-08-10 |
| PT1509600E (pt) | 2009-03-26 |
| NZ536623A (en) | 2006-05-26 |
| DK1509600T3 (da) | 2009-04-27 |
| AU2003229543A1 (en) | 2003-12-12 |
| ES2320434T3 (es) | 2009-05-22 |
| CA2485182A1 (en) | 2003-12-04 |
| US7928206B2 (en) | 2011-04-19 |
| EP1509600B1 (en) | 2008-12-31 |
| MXPA04011572A (es) | 2005-07-05 |
| ATE419337T1 (de) | 2009-01-15 |
| AU2003229543B2 (en) | 2008-03-20 |
| SI1509600T1 (sl) | 2009-06-30 |
| US20060035850A1 (en) | 2006-02-16 |
| CN1662647A (zh) | 2005-08-31 |
| EP1509600A1 (en) | 2005-03-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0306978A (pt) | ácido nucleico isolado, vetor de expressão, célula de planta, planta, método para produzir uma planta transgênica, composição, métodos para controlar o crescimento de plantas, para estimular a tolerância a estresse de uma planta e para inibir o crescimento de uma planta transgênica, e, uso de um ácido nucleico | |
| HUP0003767A2 (hu) | A kinolát-foszforibozil-transzferáz expressziójának szabályozása | |
| MX2009002377A (es) | Derivados de indazol como moduladores de cinasa asociados con el receptor de interleucina-1. | |
| WO2006076423A8 (en) | Genes and uses for plant improvement | |
| TW200628428A (en) | High calcium fertilizer composition | |
| HUP0102103A2 (hu) | A génexpresszió szabályozása növényekben dsRNS segítségével | |
| UA94582C2 (ru) | Генетическая модификация mon89788 сои и способы ее определения | |
| TR200102967T2 (tr) | Substitüsyonlu azollar | |
| NO20005613L (no) | Nukleinsyremolekyler som koder for enzymer avledet fra hvete og som er involvert i syntesen av stivelse | |
| MY147970A (en) | 2'-fluoro-2'deoxytetrahydrouridines as cytidine deaminase inhibitors | |
| MXPA06011327A (es) | Azaindoles utiles como inhibidores de jak y otras proteinas cinasas. | |
| UA39169C2 (uk) | Рекомбінантна молекула днк, яка може бути використана для одержання рослини з чоловічою стерильністю, спосіб одержання рослин із чоловічою стерильністю, спосіб одержання самозаплідненого насіння рослин з чоловічою стерильністю, олігонуклеотид | |
| DK1725666T3 (da) | Planter med reduceret aktivitet for stivelsesphosphoryleringsenzymet phosphoglucan-vand-dikinase | |
| BR0308351A (pt) | molécula de ácido nucleico isolada, planta transgênica, e, métodos para produzir uma planta transgênica e para selecionar uma planta contendo uma molécula de ácido nucleico | |
| MXPA05007792A (es) | Prodrogas de propofol derivadas de aminoacido, composiciones y usos de las mismas. | |
| DE60036477D1 (en) | Isoprenoid biosynthese | |
| HUP0002649A2 (hu) | Hímsterilitás létrehozása növényekben, avidin magas szintű expresszáltatásával | |
| HUP9800420A2 (hu) | Eljárás, és DNS-molekulák a fotoszintézis sebességének növelésére növényekben | |
| WO2004022715A3 (en) | Cloning and characterization of the broad-spectrum resistance gene pi2 | |
| ATE529430T1 (de) | Caspase-hemmer-propharmaka | |
| FI20041483A7 (fi) | Järjestelmä ja menetelmä alkion toimittamiseksi valmistettuja siemeniä varten | |
| MX2008001538A (es) | Aril piridinas y metodos para su uso. | |
| NO20034692L (no) | Nye polynukleotider og polypeptider av INF gamma-17 genet | |
| ATE419337T1 (de) | Thymidinkinasen aus pflanzen und ihre verwendung | |
| BR0114411A (pt) | métodos e composições para o tratamento de doenças inflamatórias |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |